Astrazeneca PLC/ US0463531089 /
| 2024-04-30 9:59:59 PM | Chg. +0.42 | Volume | Bid10:03:07 PM | Ask10:05:13 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 75.90USD | +0.56% | 484,011 Turnover: 28.98 mill. |
72.89Bid Size: 7 | 79.55Ask Size: 2 | 234.47 bill.USD | - | 19.76 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 3.84 USD | 81.13% |
| EPS Diluted: | - USD | - |
| Revenues per Share: | - USD | - |
| Book Value per Share: | - USD | - |
| Cash Flow per Share: | - USD | - |
| Dividend per Share: | - USD | - |
| Total | in mill. | |
| Revenues: | 45,811.00 USD | 3.29% |
| Net Income: | 5,955.00 USD | 84.48% |
| Operating Cash Flow: | 10,345.00 USD | - |
| Cash and Cash Equivalents: | 5,840.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 19.76 | - |
| P/S Ratio: | - | - |
| P/BV ratio: | - | - |
| P/CF Ratio: | - | - |
| PEG: | 0.24 | - |
| Earnings Yield: | 5.06% | - |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 234.47 bill. USD | 209.27 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 3.1 bill. | |
Profitability
| Gross Profit Margin: | 81.95% |
| EBIT Margin: | 17.88% |
| Net Profit Margin: | 13.00% |
| Return on Equity: | 15.21% |
| Return on Assets: | 5.89% |
Financial Strength
| Liquidity I / Cash Ratio: | 19.12% |
| Liquidity II / Quick Ratio: | 58.82% |
| Liquidity III / Current Ratio: | 82.03% |
| Debt / Equity Ratio: | 158.33% |
| Dynam. Debt / Equity Ratio: | 599.09% |
Efficiency
| Employees: | 89,900 |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | 509,577.31 USD |
| Net Income / Employee: | 66,240.27 USD |
| Total Assets / Employee: | 1,124,794.22 USD |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | IFRS |
| Currency: | USD |
